CMS Ventures is the corporate venture capital arm of China Medical System Holdings Limited, focusing on early-stage investments in biotech and life sciences startups. Based in Cambridge, UK, it aims to support companies with strategic interests in the Chinese market.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
CMS Ventures, established in 2020, serves as the investment arm of China Medical System Holdings Limited, a publicly listed specialty pharmaceutical company in Hong Kong. The firm is based in Cambridge, UK, and focuses on providing patient capital to early-stage biotech and life sciences startups, particularly those interested in entering the Chinese market. With a fund size of £25M, CMS Ventures targets investments in the 4Ds: drugs, devices, diagnostics, and digital health. The organization leverages its parent company's expertise and network to support startups in navigating international healthcare commercialization.
CMS Ventures invests primarily in early-stage ventures within the biotech and life sciences sectors. The firm seeks to support startups that are clinically validated and have the potential for significant impact in healthcare, particularly those looking to enter the Chinese market. By leveraging the resources and expertise of its parent company, CMS Ventures provides not just financial backing but also strategic guidance and access to a broader international network.
CMS Ventures offers more than just capital; it provides strategic support and access to China Medical System's extensive pharmaceutical platform and international commercialization network. This unique positioning allows portfolio companies to navigate the complexities of entering the Chinese market and enhances their potential for growth and success.
Organizations that do similar work to CMS Ventures.
InvestorDeerfield Management is a New York City-based investment management firm specializing in healthcare investments, managing over $15 billion in assets across more than 200 companies. The firm focuses on both public and private investments in sectors such as biotechnology, medical devices, and digital health.
InvestorInvesting in the future of life sciences and technology.
InvestorEmpowering high-growth potential companies in Asia-Pacific.
InvestorHuman Capital is a multi-stage venture capital firm that partners with exceptional founders to build companies addressing critical industry challenges. They focus on assembling high-caliber teams and deploying capital to support these ventures.
Superscout Pro
Is this page right?Reviewed · How the research works